By examining the differential hepatic gene expression of morbidly obese individuals, we and others identified interleukin 32 (IL-32) as a highly upregulated transcript in those with severe liver damage, namely metabolic dysfunction-associated steatohepatitis (MASH) significant liver fibrosis and arterial hypertension.8 The gene discussed is IL32; the disease is metabolic dysfunction-associated steatohepatitis.